Zoetis (ZTS) |
United States |
$69.222B |
37.84 |
Takeda Pharmaceutical (TAK) |
Japan |
$55.079B |
10.10 |
Astellas Pharma (ALPMY) |
Japan |
$29.863B |
18.44 |
Eisai (ESALY) |
Japan |
$20.018B |
22.20 |
Catalent (CTLT) |
United States |
$17.797B |
47.09 |
Grifols, S.A (GRFS) |
Spain |
$10.973B |
12.77 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$9.280B |
15.50 |
Neurocrine Biosciences (NBIX) |
United States |
$8.758B |
20.31 |
Ionis Pharmaceuticals (IONS) |
United States |
$7.435B |
0.00 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$7.427B |
0.00 |
United Therapeutics (UTHR) |
United States |
$7.320B |
14.22 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$7.162B |
0.00 |
IPSEN SA ADR (IPSEY) |
France |
$7.097B |
0.00 |
Orion OYJ (ORINY) |
Finland |
$5.794B |
20.11 |
Evotec AG (EVTCY) |
Germany |
$5.779B |
390.28 |
Turning Point Therapeutics (TPTX) |
United States |
$5.483B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$4.494B |
0.00 |
PTC Therapeutics (PTCT) |
United States |
$4.229B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$4.064B |
0.00 |
ChemoCentryx (CCXI) |
United States |
$3.985B |
0.00 |
Tilray (TLRY) |
Canada |
$3.715B |
0.00 |
Hypermarcas (HYPMY) |
Brazil |
$3.546B |
13.99 |
Cronos Group (CRON) |
Canada |
$3.415B |
0.00 |
Revolution Medicines (RVMD) |
United States |
$3.339B |
0.00 |
FibroGen (FGEN) |
United States |
$3.265B |
0.00 |
Pacira BioSciences (PCRX) |
United States |
$3.035B |
51.26 |
Corcept Therapeutics (CORT) |
United States |
$2.880B |
28.88 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$2.851B |
17.66 |
Xencor (XNCR) |
United States |
$2.602B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$2.114B |
17.30 |
AlloVir (ALVR) |
United States |
$1.987B |
0.00 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$1.979B |
0.00 |
Sundial Growers (SNDL) |
Canada |
$1.884B |
0.00 |
ImmunoGen (IMGN) |
United States |
$1.788B |
0.00 |
Translate Bio (TBIO) |
United States |
$1.672B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.667B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$1.627B |
12.80 |
Organogenesis Holdings (ORGO) |
United States |
$1.626B |
0.00 |
Endo (ENDP) |
Ireland |
$1.611B |
2.44 |
Heron Therapeutics (HRTX) |
United States |
$1.599B |
0.00 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$1.484B |
9.52 |
Ocular Therapeutix (OCUL) |
United States |
$1.404B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.251B |
0.00 |
Indivior (INVVY) |
United States |
$1.239B |
0.00 |
Zogenix (ZGNX) |
United States |
$1.156B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$1.104B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$1.038B |
0.00 |
Trillium Therapeutics (TRIL) |
Canada |
$1.033B |
0.00 |
Radius Health (RDUS) |
United States |
$1.007B |
0.00 |
Vectura Group (VEGPF) |
United Kingdom |
$0.991B |
0.00 |
CLINIGEN GP (CLIGF) |
United Kingdom |
$0.942B |
0.00 |
Aerie Pharmaceuticals (AERI) |
United States |
$0.880B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.868B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$0.811B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.782B |
29.59 |
Chinook Therapeutics (KDNY) |
United States |
$0.730B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.709B |
0.00 |
Calliditas Therapeutics AB (CALT) |
Sweden |
$0.686B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.653B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.602B |
0.00 |
Jounce Therapeutics (JNCE) |
United States |
$0.572B |
0.00 |
Flexion Therapeutics (FLXN) |
United States |
$0.564B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.554B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.554B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.523B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.515B |
8.53 |
Rafael Holdings (RFL) |
United States |
$0.505B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$0.497B |
0.00 |
Altimmune (ALT) |
United States |
$0.481B |
0.00 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$0.480B |
0.00 |
Acutus Medical (AFIB) |
United States |
$0.473B |
0.00 |
Summit Therapeutics (SMMT) |
United States |
$0.468B |
0.00 |
PROFOUND MEDICL (PROF) |
Canada |
$0.451B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.450B |
0.00 |
Harpoon Therapeutics (HARP) |
United States |
$0.448B |
0.00 |
AVITA Medical (RCEL) |
United States |
$0.426B |
0.00 |
DURECT (DRRX) |
United States |
$0.417B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.412B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.411B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.366B |
9.54 |
Innate Pharma SA (IPHYF) |
France |
$0.356B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.351B |
22.58 |
VYNE Therapeutics (VYNE) |
United States |
$0.343B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.326B |
0.00 |
Alpine Immune Sciences (ALPN) |
United States |
$0.308B |
0.00 |
CASI Pharmaceuticals (CASI) |
United States |
$0.281B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.255B |
8.57 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.237B |
0.00 |
CTI BioPharma (CTIC) |
United States |
$0.224B |
0.00 |
Matinas Biopharma Holdings (MTNB) |
United States |
$0.223B |
0.00 |
Novan (NOVN) |
United States |
$0.219B |
0.00 |
IMV INC (IMV) |
Canada |
$0.215B |
0.00 |
Oncternal Therapeutics (ONCT) |
United States |
$0.211B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.211B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.200B |
0.00 |
Nutriband (NTRB) |
United States |
$0.197B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.191B |
0.00 |
KemPharm (KMPH) |
United States |
$0.189B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.189B |
0.00 |
OptiNose (OPTN) |
United States |
$0.186B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.183B |
0.00 |
Taiwan Liposome (TLC) |
Taiwan |
$0.183B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.175B |
0.00 |
Oasmia Pharmaceutical AB (OASMY) |
Sweden |
$0.173B |
0.00 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.173B |
0.00 |
Ayala Pharmaceuticals (AYLA) |
Israel |
$0.171B |
0.00 |
Qilian Holding Group (QLI) |
China |
$0.166B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.159B |
0.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.157B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.157B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.157B |
0.00 |
Aziyo Biologics (AZYO) |
United States |
$0.150B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.148B |
0.00 |
ALLERGY THERAPT (AGYTF) |
United Kingdom |
$0.147B |
0.00 |
IsoRay (ISR) |
United States |
$0.145B |
0.00 |
Genocea Biosciences (GNCA) |
United States |
$0.144B |
0.00 |
MediWound (MDWD) |
Israel |
$0.137B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.128B |
0.00 |
Otonomy (OTIC) |
United States |
$0.121B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.119B |
0.00 |
Lipocine (LPCN) |
United States |
$0.117B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.109B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.102B |
0.00 |
Assertio Holdings (ASRT) |
United States |
$0.100B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.092B |
0.00 |
Aptorum Group (APM) |
Hong Kong, SAR China |
$0.091B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.091B |
24.76 |
SCYNEXIS (SCYX) |
United States |
$0.089B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.087B |
0.00 |
Baudax Bio (BXRX) |
United States |
$0.086B |
0.00 |
AgeX Therapeutics (AGE) |
United States |
$0.084B |
0.00 |
AIM ImmunoTech (AIM) |
United States |
$0.083B |
0.00 |
Sigyn Therapeutics (SIGY) |
United States |
$0.083B |
0.00 |
Brickell Biotech (BBI) |
United States |
$0.078B |
0.00 |
PolarityTE (PTE) |
United States |
$0.078B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.077B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.075B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.075B |
0.00 |
India Globalization Capital (IGC) |
United States |
$0.074B |
0.00 |
Addex Therapeutics (ADXN) |
Switzerland |
$0.070B |
0.00 |
Biomerica (BMRA) |
United States |
$0.065B |
0.00 |
Trimel Pharmaceuticals (ASPCF) |
Canada |
$0.062B |
0.00 |
CV Sciences (CVSI) |
United States |
$0.060B |
0.00 |
Inhibikase Therapeutics (IKT) |
United States |
$0.060B |
0.00 |
Plus Therapeutics (PSTV) |
United States |
$0.059B |
0.00 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.053B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.051B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.047B |
23.96 |
Mannatech (MTEX) |
United States |
$0.039B |
5.72 |
NovaBay Pharmaceuticals (NBY) |
United States |
$0.038B |
0.00 |
Neos Therapeutics (NEOS) |
United States |
$0.038B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.036B |
0.00 |
Salarius Pharmaceuticals (SLRX) |
United States |
$0.036B |
0.00 |
Can-Fite Biopharma (CANF) |
Israel |
$0.028B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.025B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.025B |
0.00 |
Midatech Pharma (MTP) |
United Kingdom |
$0.024B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.022B |
18.20 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.019B |
0.00 |
JanOne (JAN) |
United States |
$0.019B |
0.00 |
HANCOCK JAFFE (HJLI) |
United States |
$0.017B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.015B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.013B |
0.00 |
CannTrust Holdings (CTST) |
Canada |
$0.000B |
0.00 |